ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Kennedy, Hutchison Introduce Long-Awaited Bill To Reauthorize The National Cancer Program

April 3, 2009

DCPC Board approves 7 New RFAs, 2 Pas

October 21, 1994

NLMs Grateful MED Aids Data Searches

March 21, 1986

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

Fruits, Vegetables Protective Against Cancer, IARC Says

May 30, 2003